Replies to post #128820 on Amarin Corp Plc (AMRN)

[rafunrafun]

You just moved the goalpost. You went from

not have a positive impact on cardiovascular biomarkers.

to

Give me a name of the CVOT trial that failed that was done on a safe drug that significantly reduced TG, non-HDL-C, Apo B, VLDL-C, TC, and HDL-C levels

Well, there hasn't been a single CVOT that showed that reducing TG reduces CVD. There have been several CVOTs that showed that increasing HDL does not reduce CVD. Vascepa does not significantly reduce LDL. The others aren't proven biomarkers.

THIS IS WHY WE RUN TRIALS.